OtherArticle
A physiological-based pharmacokinetic model embedded with a target-mediated drug disposition mechanism can characterize single dose warfarin pharmacokinetic profiles in subjects with various CYP2C9 genotypes under different co-treatments
Shen Cheng, Darcy R Flora, Allan E. Rettie, Richard C. Brundage and Timothy S. Tracy
Drug Metabolism and Disposition November 15, 2022, DMD-AR-2022-001048; DOI: https://doi.org/10.1124/dmd.122.001048
Shen Cheng
1present affiliation: Metrum Research Group, United States
Darcy R Flora
2Present Affiliation: GRYT Health Inc., United States
Allan E. Rettie
3Dept. of Medicinal Chemistry, University of Washington, United States
Richard C. Brundage
4Experimental and Clinical Pharmacology, University of Minnesota, United States
Timothy S. Tracy
5Tracy Consultants, United States
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Warfarin PBPK model with TMDD mechanism
Shen Cheng, Darcy R Flora, Allan E. Rettie, Richard C. Brundage and Timothy S. Tracy
Drug Metabolism and Disposition November 15, 2022, DMD-AR-2022-001048; DOI: https://doi.org/10.1124/dmd.122.001048
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement